EUVIMEDEUVIMED entdecken
Crossref

Improved Efficacy and Tolerability of Antisense Oligonucleotide with Guanidine-Bridged Nucleic Acid

Takaaki Kawanobe iD, Ajaya Ram Shrestha, Hideaki Tomita

Nucleic Acid Therapeutics · 29.10.2026

DOI: 10.1177/21593337261502560 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acid Therapeutics, online erschienen am 29.10.2026. Verfasst von Takaaki Kawanobe und 2 weiteren Autor:innen. Beteiligte Einrichtung: Luxna Biotech Co., Ltd., Suita, Japan. Die Arbeit nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Guanidine-bridged nucleic acid (GuNA) is a bridged nucleic acid analog with high binding affinity toward complementary strands along with high nuclease resistance. GuNA has been developed to improve pharmacokinetics and safety profiles of phosphorothioate modified gapmers. Here, we evaluated antisense oligonucleotides (ASOs) modified with combination of GuNA and 2′- O -methoxyethyl (MOE) and found that the dual-modification strategy could significantly improve knockdown activity in vitro and in vivo . Long-term efficacy evaluation showed that intracerebroventricularly administered GuNA-modified gapmers stayed active for over 24 weeks in mouse brain. Furthermore, we observed that GuNA-modified gapmers could evade lymphocyte-derived immune responses and kept ASO-induced toxicity in check. Taken together, the results of this study demonstrate that GuNA modification can improve the functional potential of ASOs, especially in the central nervous system.

Schlagwörter

Stichwörter der Autor:innen

GuNAantisense oligonucleotideimmunotoxicity

Autor:innen und Institutionen

  • Luxna Biotech Co., Ltd., Suita, Japan.

ORCID-Profile: Takaaki Kawanobe

Zitieren

APA

Kawanobe, T., Shrestha, A. R., & Tomita, H. (2026). Improved Efficacy and Tolerability of Antisense Oligonucleotide with Guanidine-Bridged Nucleic Acid. Nucleic Acid Therapeutics. https://doi.org/10.1177/21593337261502560

Vancouver

Kawanobe T, Shrestha AR, Tomita H. Improved Efficacy and Tolerability of Antisense Oligonucleotide with Guanidine-Bridged Nucleic Acid. Nucleic Acid Therapeutics. 2026. doi:10.1177/21593337261502560

BibTeX
@article{Kawanobe2026,
  author = {Kawanobe, Takaaki and Shrestha, Ajaya Ram and Tomita, Hideaki},
  title = {Improved Efficacy and Tolerability of Antisense Oligonucleotide with Guanidine-Bridged Nucleic Acid},
  journal = {Nucleic Acid Therapeutics},
  year = {2026},
  doi = {10.1177/21593337261502560}
}
Kostenlos starten →